Form 4: Integer Holdings CEO Granted 7,543 RSUs

Integer Holdings Corp's President & CEO, Payman Khales, was granted 7,543 restricted stock units that will vest in three equal annual installments.

Summary

• Payman Khales, President & CEO and Director of Integer Holdings Corp (ITGR), was granted 7,543 Restricted Stock Units (RSUs).
• The grant date for these RSUs was October 24, 2025.
• Each RSU converts into one share of common stock on a one-for-one basis.
• The RSUs will vest in three equal annual installments, with the first vesting date on October 24, 2026.
• Following this transaction, Payman Khales beneficially owns 7,543 derivative securities (RSUs) directly.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to the CEO is a positive event for executive alignment and retention, indicating confidence in leadership and a commitment to long-term performance. It is a routine compensation event and does not reflect on the company's immediate operational or financial performance.

Positives

• The grant of 7,543 Restricted Stock Units to President & CEO Payman Khales aligns his interests with long-term shareholder value.
• The vesting schedule over three years encourages sustained performance and retention of key leadership.

Negatives

• No explicit negatives are reported in this Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing, which primarily reports an insider transaction.

Future Outlook

The 7,543 Restricted Stock Units granted to Payman Khales are scheduled to vest in three equal annual installments, commencing on October 24, 2026.

Industry Context

The grant of Restricted Stock Units is a common form of executive compensation in publicly traded companies, designed to incentivize long-term performance and align management interests with those of shareholders. This practice is standard across various industries, including the medical device and component manufacturing sector where Integer Holdings Corp operates.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of executive compensation is a widely adopted practice across global industries, including medical technology and manufacturing.
• Companies such as Medtronic plc, Stryker Corporation, and Zimmer Biomet Holdings, Inc., which operate in similar or related sectors, frequently utilize RSU grants to incentivize their executives.
• While the specific number of units (7,543) is particular to this executive and company, the structure of a multi-year vesting schedule is consistent with industry best practices aimed at executive retention and long-term value creation.

Related Party Transactions

• This filing reports an executive compensation grant, which is a standard transaction between the company and its CEO, not typically classified as an unusual related party transaction in this context.

Stakeholder Impact

• Shareholders: Minor potential future dilution upon vesting, but generally viewed positively as it aligns executive incentives with shareholder interests.
• Management: Strengthens the financial incentive and long-term commitment of the President & CEO.

Next Steps

• The Restricted Stock Units will vest in three equal annual installments, starting on October 24, 2026.

Key Dates

Keywords

Integer Holdings Corp, ITGR, Payman Khales, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Form 4, Director, CEO, President